71-year-old kidney transplant patient beats COVID-19

5-day remdesivir treatment helps elderly man recover from virus

Updated - September 28, 2020 12:05 am IST - MUMBAI

Success story:  Arvind Baval (centre) with the team of doctors at Apex Hospital before being discharged.

Success story: Arvind Baval (centre) with the team of doctors at Apex Hospital before being discharged.

A 71-year-old man, who underwent a kidney transplant five years ago, has recovered from COVID-19.

Arvind Baval was admitted to Apex Hospital in Mulund on September 16 after he tested positive. Apart from having comorbidities such as hypertension and diabetes, he had been taking three immunosuppressant drugs.

Dr. Hardik Thakker, consultant physician and infectious diseases expert at the hospital, said Mr. Baval had fever and breathlessness when he was admitted.

“A diabetic patient, with hypertension and a transplanted kidney, faces more danger in a novel coronavirus attack. This virus could do much more damage in such cases considering his age and lower immunity,” he said.

Mr. Baval was in the ICU for three days and the isolation room for a week. “Since he was on immunosuppressive therapy, his immunity was low. He was also having comorbidities which made it a very difficult case,” Dr. Thakker said.

Mr. Baval was then given remdesivir treatment for five days. “With sheer determination and aggressive treatments we were able to save him. After completing the remdesivir course, he was taken off oxygen support for five days and then discharged,” Dr. Thakker said.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.